BioMall
Savolitinib
GENERAL CATALOGUE

Savolitinib

TRC-S142903 ·

LGC Standards · Cat: TRC-S142903

₹110 – ₹160 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: TRC-S142903
CAS No: 1313725-88-0
Category: Additional Cancer Bioactive Molecules,TRC,Chiral catalysts, ligands, & reagents, Additional Cancer Bioactive Molecules,, TRC,, Chiral catalysts, ligands, & reagents
Brand: LGC Standards

More from LGC Standards

Mirin
Mirin
TRC-M364938
Additional Cancer Bioactive Molecules,TRC,Chiral catalysts, ligands, & reagents, Additional Cancer Bioactive Molecules,, TRC,, Chiral catalysts, ligands, & reagents
ORM-15341
ORM-15341
TRC-O410010
Additional Cancer Bioactive Molecules,TRC,Chiral catalysts, ligands, & reagents, Additional Cancer Bioactive Molecules,, TRC,, Chiral catalysts, ligands, & reagents
Sch 527123
Sch 527123
TRC-S200200-10MG
Additional Cancer Bioactive Molecules,TRC,Chiral catalysts, ligands, & reagents, Additional Cancer Bioactive Molecules,, TRC,, Chiral catalysts, ligands, & reagents
Toceranib Phosphate
Toceranib Phosphate
TRC-T525503
Additional Cancer Bioactive Molecules,TRC,Chiral catalysts, ligands, & reagents, Additional Cancer Bioactive Molecules,, TRC,, Chiral catalysts, ligands, & reagents
N-Acetyl-L-(-)-leucine
N-Acetyl-L-(-)-leucine
TRC-A185035
Additional Cancer Bioactive Molecules,TRC,Chiral catalysts, ligands, & reagents, Additional Cancer Bioactive Molecules,, TRC,, Chiral catalysts, ligands, & reagents
Sodium Cyanate
Sodium Cyanate
TRC-S615375-5G
Additional Cancer Bioactive Molecules,TRC,Chiral catalysts, ligands, & reagents, Additional Cancer Bioactive Molecules,, TRC,, Chiral catalysts, ligands, & reagents
Nimustine Hydrochloride
Nimustine Hydrochloride
TRC-N478253-100MG
Additional Cancer Bioactive Molecules,TRC,Chiral catalysts, ligands, & reagents, Additional Cancer Bioactive Molecules,, TRC,, Chiral catalysts, ligands, & reagents
Monomethyl Auristatin F
Monomethyl Auristatin F
TRC-M564805
Additional Cancer Bioactive Molecules,TRC,Chiral catalysts, ligands, & reagents, Additional Cancer Bioactive Molecules,, TRC,, Chiral catalysts, ligands, & reagents